Skip to main content
. Author manuscript; available in PMC: 2014 Aug 1.
Published in final edited form as: Circ Cardiovasc Genet. 2013 Jul 22;6(4):400–408. doi: 10.1161/CIRCGENETICS.113.000099

Table 4.

Population characteristics of retrospective atorvastatin and rosuvastatin dosing cohort

Atorvastatin Rosuvastatin
Number of patients 345 234
Male 203 (58.8%) 141 (60.2%)
Age at enrolment (years) 54 (14) 57 (13)
Statin dose
    5 mg 9 (2.6%) 25 (10.7%)
    10 mg 131 (38.0%) 74 (31.6%)
    20 mg 106 (30.7%) 98 (41.9%)
    40 mg 69 (20.0%) 37 (15.8%)
    80 mg 30 (8.7%) 0
Minor allelic frequency
SLCO1B1 c.388G 336/690 (48.7%) Not determined
SLCO1B1 c.521C 95/690 (13.8%) 86/468 (18.4%)
ABCG2 c.421A Not determined 50/468 (10.7%)

Data are presented as number (%), mean (S.D.).